Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagen Zac-Varghese

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|September 12, 2025
Diabetes and the kidneySagen Zac-Varghese
British Medical Bulletin|December 8, 2017
Managing diabetic kidney diseaseSagen Zac-Varghese, Peter Winocour
BMJ Simulation & Technology Enhanced Learning|May 6, 2022
Novel simulation-based human factors workshops for nearly qualified doctorsRyan Laurence Love, Sagen Zac-Varghese
BMJ Case Reports|December 26, 2022
Managing type 1 diabetes in frailtySagen Zac-Varghese, Bev Summerhayes, Peter Winocour
Discovery Medicine|December 30, 2010
Hormonal interactions between gut and brainSagen Zac-Varghese, Tricia Tan, Stephen Robert Bloom
Current Opinion in Pharmacology|October 25, 2011
Translational studies on PYY as a novel target in obesitySagen Zac-Varghese, Akila De Silva, Stephen R Bloom
Gut|March 31, 2015
Weight loss in a man from West Africa. S. stercoralis hyperinfectionRabia Topan, Sophie James, Benjamin H Mullish, et al.
Disease Models & Mechanisms|September 6, 2014
The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage in miceSagen Zac-Varghese, Stefan Trapp, Paul Richards, et al.
Plos One|March 25, 2016
Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose ToleranceSophie R Sayers, Frank Reimann, Fiona M Gribble, et al.
British Journal of Clinical Pharmacology|August 13, 2011
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420Tricia M Tan, Benjamin C T Field, James S Minnion, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|September 12, 2025
Diabetes and the kidneySagen Zac-Varghese
British Medical Bulletin|December 8, 2017
Managing diabetic kidney diseaseSagen Zac-Varghese, Peter Winocour
BMJ Simulation & Technology Enhanced Learning|May 6, 2022
Novel simulation-based human factors workshops for nearly qualified doctorsRyan Laurence Love, Sagen Zac-Varghese
BMJ Case Reports|December 26, 2022
Managing type 1 diabetes in frailtySagen Zac-Varghese, Bev Summerhayes, Peter Winocour
Discovery Medicine|December 30, 2010
Hormonal interactions between gut and brainSagen Zac-Varghese, Tricia Tan, Stephen Robert Bloom
Current Opinion in Pharmacology|October 25, 2011
Translational studies on PYY as a novel target in obesitySagen Zac-Varghese, Akila De Silva, Stephen R Bloom
Gut|March 31, 2015
Weight loss in a man from West Africa. S. stercoralis hyperinfectionRabia Topan, Sophie James, Benjamin H Mullish, et al.
Disease Models & Mechanisms|September 6, 2014
The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage in miceSagen Zac-Varghese, Stefan Trapp, Paul Richards, et al.
Plos One|March 25, 2016
Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose ToleranceSophie R Sayers, Frank Reimann, Fiona M Gribble, et al.
British Journal of Clinical Pharmacology|August 13, 2011
Pharmacokinetics, adverse effects and tolerability of a novel analogue of human pancreatic polypeptide, PP 1420Tricia M Tan, Benjamin C T Field, James S Minnion, et al.
Pageof 2